-
Signature
-
Laura Heiman, Attorney-in-fact
-
Stock symbol
-
MCK
-
Transactions as of
-
Jan 3, 2024
-
Transactions value $
-
-$4,786,584
-
Form type
-
4
-
Date filed
-
1/4/2024, 04:51 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
MCK |
Common Stock |
Options Exercise |
$1.46M |
+10.1K |
+23.29% |
$144.43 |
53.6K |
Jan 3, 2024 |
Direct |
F1 |
transaction |
MCK |
Common Stock |
Sale |
-$4.86M |
-10.1K |
-18.89% |
$480.00 |
43.4K |
Jan 3, 2024 |
Direct |
F1 |
transaction |
MCK |
Common Stock |
Options Exercise |
$485K |
+3.91K |
+9% |
$123.99 |
47.4K |
Jan 3, 2024 |
Direct |
F1 |
transaction |
MCK |
Common Stock |
Sale |
-$1.88M |
-3.91K |
-8.25% |
$480.00 |
43.4K |
Jan 3, 2024 |
Direct |
F1 |
holding |
MCK |
Common Stock |
|
|
|
|
|
214 |
Jan 3, 2024 |
By the McKesson Corporation 401(k) Retirement Savings Plan |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
MCK |
Employee Stock Option (Right-to-buy) |
Options Exercise |
$0 |
-10.1K |
-100% |
$0.00* |
0 |
Jan 3, 2024 |
Common Stock |
10.1K |
$144.43 |
Direct |
F2 |
transaction |
MCK |
Employee Stock Option (Right-to-buy) |
Options Exercise |
$0 |
-3.91K |
-100% |
$0.00* |
0 |
Jan 3, 2024 |
Common Stock |
3.91K |
$123.99 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: